Future of antivirals in COVID-19: The case of favipiravir

Chia Siang Kow; Dinesh Sangarran Ramachandram; Syed Shahzad Hasan

doi:10.1016/j.intimp.2021.108455

Future of antivirals in COVID-19: The case of favipiravir

Chia Siang Kow, Dinesh Sangarran Ramachandram, Syed Shahzad Hasan

Research output: Contribution to journal › Letter › peer-review

Original language	English
Article number	108455
Number of pages	3
Journal	International Immunopharmacology
Volume	103
Early online date	13 Dec 2021
DOIs	https://doi.org/10.1016/j.intimp.2021.108455
Publication status	Published - 1 Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.intimp.2021.108455Licence: Unspecified

Cite this

@article{6e3c76d319654fcaaa283c92591ff4ec,

title = "Future of antivirals in COVID-19: The case of favipiravir",

keywords = "Antivirals, Favipiravir, Covid 19",

author = "Kow, {Chia Siang} and Ramachandram, {Dinesh Sangarran} and Hasan, {Syed Shahzad}",

year = "2022",

month = feb,

day = "1",

doi = "10.1016/j.intimp.2021.108455",

language = "English",

volume = "103",

journal = "International Immunopharmacology",

issn = "1567-5769",

publisher = "Elsevier",

}

TY - JOUR

T1 - Future of antivirals in COVID-19

T2 - The case of favipiravir

AU - Kow, Chia Siang

AU - Ramachandram, Dinesh Sangarran

AU - Hasan, Syed Shahzad

PY - 2022/2/1

Y1 - 2022/2/1

KW - Antivirals

KW - Favipiravir

KW - Covid 19

UR - http://www.scopus.com/inward/record.url?scp=85121636743&partnerID=8YFLogxK

U2 - 10.1016/j.intimp.2021.108455

DO - 10.1016/j.intimp.2021.108455

M3 - Letter

AN - SCOPUS:85121636743

VL - 103

JO - International Immunopharmacology

JF - International Immunopharmacology

SN - 1567-5769

M1 - 108455

ER -

Future of antivirals in COVID-19: The case of favipiravir

UN SDGs

Access to Document

Other files and links

Cite this